Quantum Enhanced Computing Platform for Pharmaceutical R&D - QuPharma

Project funded by UK Research and Innovation (UKRI) (ISCF, Collaborative R&D), research institution: SEEQC UK LIMITED. Award value (Gateway to Research): GBP 5,069,355, as stated by the source. Runs 2022-03-01 to 2025-03-31. Source: Gateway to Research (UK Research and Innovation) (national funding data, not CORDIS).

Original source.

Source: Gateway to Research (UK Research and Innovation), UK Research and Innovation (UKRI). Retrieved 2026-10-23. Licence: Open Government Licence v3.0; contains public sector information licensed under the Open Government Licence v3.0. Selected metadata, adapted presentation; the publisher's record is authoritative. No endorsement by the source is implied. Licence: Open Government Licence v3.0.

AI-assisted summary: The QuPharma project, funded by UK Research and Innovation, focuses on quantum enhanced computing for pharmaceutical R&D. It is awarded GBP 5,069,355 and runs from March 1, 2022, to March 31, 2025. Suggested technology pillar: computing. Generated by AI from the public source text; it may contain errors and the original source is authoritative.